IshidaCIkedaTKomaiKet al. Contiguous and symmetrical disease expansion and massive necrosis of the cerebral white matter in a patient with neuromyelitis optica. Mult Scler2018; 24: 1258–1261.
3.
WingerchukDMHogancampWFO’BrienPCet al. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology1999; 53(5): 1107–1114.
LennonVAWingerchukDMKryzerTJet al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet2004; 364(9451): 2106–2112.
6.
LennonVAKryzerTJPittockSJet al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med2005; 202(4): 473–477.
7.
PittockSJWeinshenkerBGLucchinettiCFet al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol2006; 63(7): 964–968.
8.
WingerchukDMBanwellBBennettJLet al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology2015; 85(2): 177–189.
9.
KimHJPaulFLana-PeixotoMAet al. MRI characteristics of neuromyelitis optica spectrum disorder: An international update. Neurology2015; 84(11): 1165–1173.
Kıyat-AtamerAEkizoğluETüzünEet al. Long-term MRI findings in neuromyelitis optica: Seropositive versus seronegative patients. Eur J Neurol2013; 20(5): 781–787.
13.
McKeonALennonVALotzeTet al. CNS aquaporin-4 autoimmunity in children. Neurology2008; 71(2): 93–100.
14.
TenembaumSChitnisTNakashimaIet al. Neuromyelitis optica spectrum disorders in children and adolescents. Neurology2016; 87(9Suppl. 2): S59–S66.
15.
CollonguesNMarignierRZéphirHet al. Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology2010; 75(12): 1084–1088.
16.
PfisterHOllertMFröhlichLFet al. Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood2004; 104(5): 1411–1418.
17.
SinneckerTDörrJPfuellerCFet al. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology2012; 79(7): 708–714.
